Literature DB >> 1316370

Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS.

S Safrin1, A Arvin, J Mills, R Ashley.   

Abstract

Herpes simplex virus type 2 (HSV-2) seroprevalence in 68 patients with AIDS was 77% by Western blot (immunoblot) and 44% by glycoprotein G-2 immunoassay. Each of 16 patients with culture-proven HSV-2 infection was positive by Western blot versus 8 by glycoprotein G-2 immunoassay. No differences in age, race, duration of AIDS, acyclovir usage, or HSV-1 seroprevalence were found to explain differences in sensitivity.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1316370      PMCID： PMC265273          DOI： 10.1128/jcm.30.5.1312-1314.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.

Authors:  S D Holmberg; J A Stewart; A R Gerber; R H Byers; F K Lee; P M O'Malley; A J Nahmias
Journal:  JAMA       Date:  1988-02-19       Impact factor: 56.272

2.  Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.

Authors:  W M Sullender; L L Yasukawa; M Schwartz; L Pereira; P A Hensleigh; C G Prober; A M Arvin
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

3.  A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection.

Authors:  J J Gibson; C A Hornung; G R Alexander; F K Lee; W A Potts; A J Nahmias
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

4.  Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples.

Authors:  D I Bernstein; M A Lovett; Y J Bryson
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

5.  Detection of herpes simplex virus type 2-specific antibody with glycoprotein G.

Authors:  F K Lee; R M Coleman; L Pereira; P D Bailey; M Tatsuno; A J Nahmias
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

6.  Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.

Authors:  D Gold; R Ashley; G Solberg; H Abbo; L Corey
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men.

Authors:  L A Kingsley; J Armstrong; A Rahman; M Ho; C R Rinaldo
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

8.  Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus.

Authors:  K S Erlich; L Hauer; J Mills
Journal:  J Med Virol       Date:  1988-09       Impact factor: 2.327

9.  Clinical and serologic features of herpes simplex virus infection in patients with AIDS.

Authors:  S Safrin; R Ashley; C Houlihan; P S Cusick; J Mills
Journal:  AIDS       Date:  1991-09       Impact factor: 4.177

10.  The association between genital ulcer disease and acquisition of HIV infection in homosexual men.

Authors:  W E Stamm; H H Handsfield; A M Rompalo; R L Ashley; P L Roberts; L Corey
Journal:  JAMA       Date:  1988-09-09       Impact factor: 56.272
View more
  11 in total

1.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.

Authors:  Thomas L Cherpes; Rhoda L Ashley; Leslie A Meyn; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors:  Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

4.  Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2.

Authors:  D S Schmid; D R Brown; R Nisenbaum; R L Burke; D Alexander; R Ashley; P E Pellett; W C Reeves
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

5.  Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.

Authors:  R L Ashley; L Wu; J W Pickering; M C Tu; L Schnorenberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera.

Authors:  A M Eis-Hübinger; M Däumer; B Matz; K E Schneweis
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 7.  Management of herpes simplex and varicella-zoster virus infections.

Authors:  K S Erlich
Journal:  West J Med       Date:  1997-03

Review 8.  Laboratory techniques in the diagnosis of herpes simplex infection.

Authors:  R L Ashley
Journal:  Genitourin Med       Date:  1993-06

9.  Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Authors:  Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.

Authors:  Wayne Hogrefe; Xin Su; James Song; Rhoda Ashley; Lilly Kong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.